About us

We develop and manufacture biosimilars, partnering with biotechnology companies around the planet, to improve patient access to much needed therapies.

We create quality biosimilars with passion from our three sites in Poland and the Netherlands, these are some of the most modern and largest facilities in Europe.

Our history

Creating quality biologics with passion

We are passionate about providing safe and effective medicines to patients.
We work with dedication and find innovative solutions.
We are committed to positive outcomes and delivering projects on time, to specification.

Delivering on our commitments

We are self-motivated to reach the end result - “wait and see” is not in our vocabulary.
We are experts in managing projects and communicate clearly and concisely.
We anticipate potential issues before they arise, always ensuring high quality outcomes.

Being respectful and transparent

We are open and honest without exception.
We value everyone equally and always treat others with respect.
We like to collaborate and can rely on each other.

Our sites

With state-of-the-art facilities across Europe, Polpharma Biologics is at the forefront of the next wave in biotechnology, leveraging our knowledge, capabilities and footprint to develop innovative solutions for the industry.

Gdańsk

Our Gdansk site includes mammalian and microbial R&D and manufacturing facilities for mid-scale production including drug product and fill finish.

Warsaw

Our Warsaw site is one of the largest biologics manufacturing sites in Europe, with capabilities for preclinical, clinical and commercial supply to EU and US standards.

Utrecht

Our Utrecht site is one of innovation and leads the discovery, optimization and development of novel biologics and biosimilars as well as being home to our industry leading cell line development platform.

Our sites

Learn more

Gdańsk

Our Gdansk site includes mammalian and microbial R&D and manufacturing facilities for mid-scale production including drug product and fill finish.
Warsaw

Our Warsaw site is one of the largest biologics manufacturing sites in Europe, with capabilities for preclinical, clinical and commercial supply to EU and US standards.
Utrecht

Our Utrecht site is one of innovation and leads the discovery, optimization and development of novel biologics and biosimilars as well as being home to our industry leading cell line development platform.

Learn more

Innovation in Poland

Over the last decade Polpharma Biologics has created a biotechnology sector almost from scratch in Poland. We consistently invest, not only laboratories and production lines, but also in know-how, driving growth of highly-qualified jobs, as well as developing cooperation between science and business.

Learn more